Tango Therapeutics, Inc. · NASDAQ:TNGX
Adage Capital Management, L.P. reported a 7.88% stake in Tango Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 12, 2026
Adage Capital Management, L.P. reported a 7.88% stake in Tango Therapeutics, Inc., 10,607,924 shares, as a passive investor on Dec 31, 2025. Filed Feb 12, 2026 (Schedule 13G).
- Stake
- 7.88%
- Shares
- 10,607,924
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 7.88% | 10,607,924 |
| Robert Atchinson | 7.88% | 10,607,924 |
| Phillip Gross | 7.88% | 10,607,924 |
Source
Related
- Tango Therapeutics, Inc.
- Adage Capital Management, L.P.
- Tango Therapeutics, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Nov 13, 2025
- Schedule 13G · Adage Capital Management, L.P. · Aug 12, 2025
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026